First quarter report Q1-2023
· Study 0205 is progressing, with last patient expected in Q3 · Protocol finalized for study 0202, ready for submission in Q2 · Good progress with the commercialization strategy Cessatech A/S (“Cessatech” or the “Company”) today releases its results for the period 1 January – 31 March 2023. The first quarter report is available as an attached document to this press release and on www.cessatech.com under Investor/Filings & Reports. The Company is progressing well with planned activities, finalization of recruitment of pivotal study 0205 is expected in the third quarter of 2023 (a